BrandonEdwardKremerMDPhD

PubMed

• 2 citations
  Association of Minimal Residual Disease Negativity Rates With Progression Free Survival in Frontline Therapy Trials for Newly Diagnosed Multiple Myeloma: A Meta-analysis.
  Joseph Ficek, Eleftheria Kalaitzaki, Shuai Sammy Yuan, Alessandra Tosolini, Ling Du, Brandon E Kremer, Katherine Davy, Helen Zhou, Tai-Tsang Chen> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 May 1
• 19 citations
  Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of NUT carcinoma and other cancers: results of a phase I/II open-label, ...
  Sophie Cousin, Jean-Yves Blay, Irene Braña Garcia, Johann S. de Bono, Christophe Le Tourneau, Victor Moreno, Jose Manuel Trigo, Christine L. Hann, Arun Azad, Seock-Ah ...> ;International Journal of Cancer. 2021 Nov 1
• 23 citations
  Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.
  Kenneth C. Anderson, Daniel Auclair, Stacey J Adam, Amit Agarwal, Melissa Anderson, Hervé Avet-Loiseau, Mark Bustoros, Jessica R. Chapman, Dana E. Connors, Ajeeta B Da...> ;Clinical Cancer Research. 2021 Jul 28
• 3 citations
  Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide.
  Brandon E. Kremer, Donald E. Tsai, Fotini Debonera, Patti L Cohen, Stephen J. Schuster> ;Leukemia & Lymphoma. 2018 Mar 1
• 8 citations
  A pilot trial of quantitative Epstein–Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein–Barr virus p...
  Donald E. Tsai, Marlise R. Luskin, Brandon E. Kremer, Albert K. Chung, Sharon Arnoldi, Vikram R Paralkar, Sunita D. Nasta, Edward A. Stadtmauer, Stephen J. Schuster, M...> ;Leukemia & Lymphoma. 2015 May 1
• 102 citations
  Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
  Alexander Stoeck, Serguei Lejnine, Andrew S. Truong, Li Pan, Hongfang Wang, Chongzhi Zang, Jing Yuan, Christopher Ware, John Maclean, Philip W. Garrett-engele, Michael...> ;Cancer Discovery. 2014 Aug 7
• 37 citations
  Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.
  Brandon E. Kremer, Ran Reshef, Jamal G. Misleh, Jason D. Christie, Vivek N. Ahya, Nancy P. Blumenthal, Robert M. Kotloff, Denis Hadjiliadis, Edward A. Stadtmauer, Step...> ;The Journal of Heart and Lung Transplantation. 2012 Mar 1
• 170 citations
  Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7.
  Brandon E. Kremer, Laura Adang, Ian G. Macara> ;Cell. 2007 Sep 7
• 152 citations
  Mammalian Septins Regulate Microtubule Stability through Interaction with the Microtubule-binding Protein MAP4
  Brandon E. Kremer, Timothy A.J. Haystead, Ian G. Macara> ;Molecular Biology of the Cell. 2005 Oct 1
• 295 citations
  Myocardin Is a Key Regulator of CArG-Dependent Transcription of Multiple Smooth Muscle Marker Genes
  Tadashi Yoshida, Sanjay Sinha, Frédéric Dandré, Brian R. Wamhoff, Mark H. Hoofnagle, Brandon E. Kremer, Da-Zhi Wang, Eric N. Olson, Gary K. Owens> ;Circulation Research. 2003 May 2
• 132 citations
  Borg/septin interactions and the assembly of mammalian septin heterodimers, trimers, and filaments.
  Peter J. Sheffield, Carey J. Oliver, Brandon E. Kremer, Sitong Sheng, Zhifeng Shao, Ian G. Macara> ;The Journal of Biological Chemistry. 2003 Jan 31
• Join now to see all

Abstracts/Posters

• A Phase I/II Study to Investigate the Safety and Clinical Activity of the Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 in Subjects with Myelodysplastic Sy...
  Brandon E Kremer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• A Phase I Study of Molibresib (GSK525762), a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of a Phase I/II Open Label Sin... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018